22-19911314-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006440.5(TXNRD2):​c.662+63T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.603 in 1,310,984 control chromosomes in the GnomAD database, including 244,987 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 33451 hom., cov: 31)
Exomes 𝑓: 0.60 ( 211536 hom. )

Consequence

TXNRD2
NM_006440.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.58

Publications

7 publications found
Variant links:
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]
TXNRD2 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial glucocorticoid deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glucocorticoid deficiency 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-19911314-A-G is Benign according to our data. Variant chr22-19911314-A-G is described in ClinVar as [Benign]. Clinvar id is 678039.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TXNRD2NM_006440.5 linkc.662+63T>C intron_variant Intron 8 of 17 ENST00000400521.7 NP_006431.2 Q9NNW7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TXNRD2ENST00000400521.7 linkc.662+63T>C intron_variant Intron 8 of 17 1 NM_006440.5 ENSP00000383365.1 Q9NNW7-1

Frequencies

GnomAD3 genomes
AF:
0.654
AC:
99332
AN:
151876
Hom.:
33397
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.771
Gnomad AMI
AF:
0.531
Gnomad AMR
AF:
0.709
Gnomad ASJ
AF:
0.645
Gnomad EAS
AF:
0.922
Gnomad SAS
AF:
0.737
Gnomad FIN
AF:
0.618
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.633
GnomAD4 exome
AF:
0.596
AC:
690983
AN:
1158990
Hom.:
211536
Cov.:
16
AF XY:
0.599
AC XY:
353590
AN XY:
590354
show subpopulations
African (AFR)
AF:
0.778
AC:
21363
AN:
27464
American (AMR)
AF:
0.774
AC:
33915
AN:
43816
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
15649
AN:
24244
East Asian (EAS)
AF:
0.913
AC:
34860
AN:
38194
South Asian (SAS)
AF:
0.712
AC:
56731
AN:
79706
European-Finnish (FIN)
AF:
0.616
AC:
32668
AN:
53008
Middle Eastern (MID)
AF:
0.562
AC:
2900
AN:
5162
European-Non Finnish (NFE)
AF:
0.552
AC:
461915
AN:
837068
Other (OTH)
AF:
0.616
AC:
30982
AN:
50328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
14089
28177
42266
56354
70443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11552
23104
34656
46208
57760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.654
AC:
99448
AN:
151994
Hom.:
33451
Cov.:
31
AF XY:
0.661
AC XY:
49122
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.771
AC:
31979
AN:
41460
American (AMR)
AF:
0.710
AC:
10855
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
2238
AN:
3468
East Asian (EAS)
AF:
0.923
AC:
4771
AN:
5170
South Asian (SAS)
AF:
0.738
AC:
3555
AN:
4816
European-Finnish (FIN)
AF:
0.618
AC:
6510
AN:
10536
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.553
AC:
37574
AN:
67944
Other (OTH)
AF:
0.636
AC:
1339
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1677
3354
5032
6709
8386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
796
1592
2388
3184
3980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.620
Hom.:
11096
Bravo
AF:
0.667
Asia WGS
AF:
0.805
AC:
2799
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.12
DANN
Benign
0.61
PhyloP100
-2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs885987; hg19: chr22-19898837; API